Roffman Miller Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Sell
20,126
-232
-1% -$20.3K 0.1% 69
2026
Q1
$1.74M Sell
20,358
-306
-1% -$27.3K 0.1% 70
2025
Q4
$1.63M Sell
20,664
-2,688
-12% -$211K 0.09% 69
2025
Q3
$1.87M Sell
23,352
-669
-3% -$57.1K 0.1% 66
2025
Q2
$2.18M Sell
24,021
-338
-1% -$30.9K 0.13% 57
2025
Q1
$2.28M Buy
24,359
+5,845
+32% +$523K 0.14% 58
2024
Q4
$1.68M Sell
18,514
-1,722
-9% -$164K 0.1% 61
2024
Q3
$2.1M Sell
20,236
-829
-4% -$84.5K 0.13% 60
2024
Q2
$2.04M Buy
21,065
+1,546
+8% +$143K 0.13% 59
2024
Q1
$1.76M Sell
19,519
-678
-3% -$57.4K 0.12% 61
2023
Q4
$1.61M Sell
20,197
-8,134
-29% -$612K 0.12% 60
2023
Q3
$2.01M Sell
28,331
-2,546
-8% -$190K 0.16% 53
2023
Q2
$2.38M Sell
30,877
-2,933
-9% -$227K 0.18% 53
2023
Q1
$2.54M Sell
33,810
-4,263
-11% -$317K 0.2% 51
2022
Q4
$3M Sell
38,073
-7,745
-17% -$581K 0.25% 51
2022
Q3
$3.22M Sell
45,818
-3,955
-8% -$310K 0.29% 50
2022
Q2
$3.99M Sell
49,773
-47,431
-49% -$3.71M 0.35% 51
2022
Q1
$7.37M Sell
97,204
-166,975
-63% -$13.2M 0.55% 45
2021
Q4
$22.5M Sell
264,179
-3,203
-1% -$250K 1.53% 28
2021
Q3
$20.2M Sell
267,382
-151,655
-36% -$12M 1.5% 29
2021
Q2
$21.3M Buy
419,037
+8,625
+2% +$705K 1.62% 28
2021
Q1
$20.4M Buy
410,412
+46,428
+13% +$3.64M 1.7% 27
2020
Q4
$21.7M Buy
363,984
+108,634
+43% +$8.98M 1.88% 22
2020
Q3
$19.7M Buy
255,350
+2,697
+1% +$206K 1.91% 21
2020
Q2
$18.5M Buy
252,653
+3,738
+2% +$266K 1.84% 22
2020
Q1
$16.5M Buy
248,915
+808
+0.3% +$57K 2.07% 22
2019
Q4
$17.1M Buy
248,107
+1,041
+0.4% +$71K 1.71% 29
2019
Q3
$18.2M Sell
247,066
-2,822
-1% -$205K 1.9% 28
2019
Q2
$17.9M Buy
249,888
+5,351
+2% +$380K 1.92% 29
2019
Q1
$16.8M Buy
244,537
+13,033
+6% +$842K 1.91% 30
2018
Q4
$13.8M Sell
231,504
-2,485
-1% -$155K 1.8% 31
2018
Q3
$15.7M Buy
233,989
+5,092
+2% +$339K 1.74% 31
2018
Q2
$14.8M Buy
228,897
+10,057
+5% +$658K 1.81% 31
2018
Q1
$15.7M Buy
218,840
+15,122
+7% +$1.09M 1.99% 30
2017
Q4
$15.4M Buy
203,718
+2,932
+1% +$214K 1.9% 31
2017
Q3
$14.6M Buy
200,786
+8,170
+4% +$589K 1.93% 29
2017
Q2
$14.3M Buy
192,616
+6,985
+4% +$519K 1.96% 28
2017
Q1
$13.6M Buy
185,631
+6,423
+4% +$450K 1.92% 29
2016
Q4
$11.7M Buy
179,208
+8,880
+5% +$609K 1.77% 32
2016
Q3
$12.6M Buy
170,328
+1,983
+1% +$147K 2.04% 29
2016
Q2
$12.3M Buy
168,345
+4,886
+3% +$348K 2.02% 29
2016
Q1
$11.5M Buy
163,459
+6,609
+4% +$440K 1.98% 29
2015
Q4
$10.4M Buy
156,850
+2,377
+2% +$158K 1.91% 31
2015
Q3
$9.8M Buy
154,473
+2,447
+2% +$160K 1.92% 30
2015
Q2
$9.94M Buy
152,026
+746
+0.5% +$50.6K 1.89% 29
2015
Q1
$10.5M Buy
151,280
+1,648
+1% +$114K 2.01% 27
2014
Q4
$10.4M Buy
149,632
+1,128
+0.8% +$76.2K 2.01% 28
2014
Q3
$9.69M Buy
148,504
+5,499
+4% +$363K 1.98% 25
2014
Q2
$9.75M Buy
143,005
+5,526
+4% +$370K 2.06% 25
2014
Q1
$8.92M Buy
137,479
+3,428
+3% +$216K 1.98% 25
2013
Q4
$8.74M Buy
134,051
+5,588
+4% +$358K 2.01% 25
2013
Q3
$7.62M Buy
128,463
+7,497
+6% +$444K 1.92% 25
2013
Q2
$6.93M Buy
+120,966
New +$7.18M 1.85% 27

Other funds holding CL

Roffman Miller Associates's CL Position: Q2 2026 in Review

Roffman Miller Associates reduced its Colgate-Palmolive (CL) stake by 1.1% in Q2 2026, selling an estimated $20.3K and leaving 20,126 shares worth $1.85M. The position accounts for 0.1% of the portfolio, ranked #69.

Roffman Miller Associates first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.5M in Q4 2021. 894 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Roffman Miller Associates held 20,126 shares of Colgate-Palmolive worth $1.85M as of Q2 2026.
  • Roffman Miller Associates sold 232 Colgate-Palmolive shares in Q2 2026, an estimated $20.3K.
  • Colgate-Palmolive made up 0.1% of Roffman Miller Associates's portfolio in Q2 2026, its #69 holding.
  • Roffman Miller Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Roffman Miller Associates's Colgate-Palmolive position peaked at $22.5M in Q4 2021.
  • 894 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Roffman Miller Associates's 13F filing for Q2 2026, filed 13 Jul 2026.